0001387131-19-003731.txt : 20190515
0001387131-19-003731.hdr.sgml : 20190515
20190515170317
ACCESSION NUMBER: 0001387131-19-003731
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190513
FILED AS OF DATE: 20190515
DATE AS OF CHANGE: 20190515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Collins Cooper C.
CENTRAL INDEX KEY: 0001485508
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00100
FILM NUMBER: 19829436
MAIL ADDRESS:
STREET 1: 33219 FOREST WEST DRIVE
CITY: MAGNOLIA
STATE: TX
ZIP: 77354
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TherapeuticsMD, Inc.
CENTRAL INDEX KEY: 0000025743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870233535
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6800 BROKEN SOUND PARKWAY NW
STREET 2: THIRD FLOOR
CITY: BOCA RATON
STATE: FL
ZIP: 33487
BUSINESS PHONE: 561-961-1911
MAIL ADDRESS:
STREET 1: 6800 BROKEN SOUND PARKWAY NW
STREET 2: THIRD FLOOR
CITY: BOCA RATON
STATE: FL
ZIP: 33487
FORMER COMPANY:
FORMER CONFORMED NAME: AMHN, Inc.
DATE OF NAME CHANGE: 20090930
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF ENTERPRISES INC
DATE OF NAME CHANGE: 19970915
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF OIL CO
DATE OF NAME CHANGE: 19920703
4
1
collins-form4_051319.xml
OWNERSHIP DOCUMENT
X0306
4
2019-05-13
0
0000025743
TherapeuticsMD, Inc.
TXMD
0001485508
Collins Cooper C.
6800 BROKEN SOUND PARKWAY NW,
3RD FLOOR
BOCA RATON,
FL
33487
1
0
0
0
Common Stock
2019-05-13
4
P
0
30000
3.329
A
66000
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.32 to $3.33, inclusive. The Reporting Person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Cooper C. Collins
2019-05-15